GW Pharmaceuticals (GWP)

 

GWP Share PerformanceMore

52 week high0.0000
52 week low0.0000
52 week change 0.0000 (0.00%)
4 week volume0 28/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

12 AIM shares in the 1,000% club

With AIM back near 1,000 for the first time in nine years, former AIM writer of the year Andrew Hore analyses the best ...

Cancellation - GW Pharmaceuticals Plc

RNS Number: 8466Q AIM 05 December 2016 NOTICE 05/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM GW PHARMACEUTICALS PLC At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 05/12/2016 7:00am ORDINARY SHARES OF 0.1P EACH, FULLY PAID (30544...

American Society of Epilepsy Annual Meeting

RNS Number: 7013Q GW Pharmaceuticals PLC 01 December 2016 GW Pharmaceuticals plc Announces Epidiolex (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting - Presentations include clinical results from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet Syndrome, as well as additional ind...

GW Pharmaceuticals schedules FY results

GW Pharmaceuticals will announce its fourth quarter and year-end financial results for the period ending 30 September o...

Notice of Q4 and year-end results

RNS Number: 4818Q GW Pharmaceuticals PLC 30 November 2016 GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 London, UK, 30 Nov 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and comm...

Holding(s) in Company

RNS Number: 9985P GW Pharmaceuticals PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii GW Pharmaceuticals PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting r...

GW chief exec to present Piper Jaffray conference

GW Pharmaceuticals chief executive Justin Gover will present at the 28th annual Piper Jaffray Healthcare Conference at ...

Presenting at Piper Jaffray Healthcare Conference

RNS Number: 8355P GW Pharmaceuticals PLC 22 November 2016 GW Pharmaceuticals to Present at the 28 th Annual Piper Jaffray Healthcare Conference on 29 November London, UK, 22 November 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and comm...

Equity Research (GWP)

edison investment research
GW Pharmaceuticals plc
08/06/2016
Data from two Phase III trials (with 171 and 225 patients, respectively) of Epidiolex in Lennox-Gastaut (LGS) patients are coming soon with the first trial to report out in June with the second...
edison investment research
GW Pharmaceuticals plc
25/02/2016
With four Phase III trials of Epidiolex (cannabidiol, or CBD) in various forms of pediatric epilepsy, two for Dravet syndrome and two for Lennox-Gastaut syndrome (LGS) expected to provide top-line...
edison investment research
GW Pharmaceuticals plc
25/02/2016
With four Phase III trials of Epidiolex (cannabidiol or CBD) in various forms of pediatric epilepsy, two for Dravet syndrome and two for Lennox-Gastaut syndrome (LGS) expected to provide top-line...

Latest discussion posts More

  • Re: GW AIM delisting - advice please

    Hi MischasMate, did you find a broker as I am in the same position. Thanks
    22-Dec-2016
    JC74B
  • Re: GW AIM delisting - advice please

    I don't know for sure, but AJ Bell/YouInvest have been very good for me (low commission, helpful when it came to Open Offers for GKP and SXX) and I do know that I can trade ...
    14-Dec-2016
    in4apennyin4amil1
  • GW AIM delisting - advice please

    My missus holds a load of GW & received 2 share certs from iii for her total holding (several K value in total) - well past any time to do ought about it as she was in hospital ...
    14-Dec-2016
    mishasMate

Users' HoldingsMore

Users who hold GW Pharmaceuticals also hold..
GW Pharmaceuticals PLC66%
VODAFONE GRP.33%
BR.AMER.TOB.33%
India Midcap A Inc GBP16%
ROYAL MAIL16%

Codes & Symbols

ISINGB0030544687
SymbolsGWP, LSE:GWP, GWP.L, GWP:LN, LON:GWP, XLON:GWP